Explanation

When a PMHNP inherits a caseload, they assume full clinical responsibility for the patients from the point of assumption. If monitoring gaps are identified, the PMHNP must address them regardless of who was responsible for the original lapse. Second-generation antipsychotics carry well-documented metabolic risks including weight gain, dyslipidemia, hyperglycemia, and new-onset diabetes. Standard monitoring guidelines recommend baseline and periodic metabolic panels, fasting glucose or HbA1c, lipid profiles, and weight/BMI measurements. Failure to monitor creates both patient risk and provider liability. The appropriate action is to order overdue monitoring immediately, document the identified gap, and establish a prospective monitoring schedule.

Key Takeaway

The PMHNP is responsible for care from the point they assume it.